Promising alternative strategy for islet transplantation in people with type 1 diabetes

In people with type 1 diabetes, the body's immune system attacks and destroys insulin-producing β cells that control blood glucose levels and are part of a group of cells in the pancreas called pancreatic islets.

Related Keywords

Massachusetts ,United States ,Ivya Rosales ,Rudy Matheson ,Qiang Fu ,Emily Henderson ,Zhao Luo ,Alexander Zhang ,Zhongliang Zou ,Tao Chen ,Colew Peters ,Jamesf Markmann ,Kangm Lee ,Zhenjuan Wang ,Guoping Li ,Haval Shirwan ,Zhihong Yang ,Dillon Ren Rong ,Diabetes Research Foundation ,Surgery At Harvard Medical School ,Human Islet Cell Processing Special Service ,National Institutes Of Health ,Division Of Transplant Surgery ,Cell Reports Medicine ,Massachusetts General Hospital ,Mass General Brigham ,Hong Ping Deng ,Transplant Surgery ,Harvard Medical ,Discovery Industry Focus ,Cell Processing Special Service ,Clinical Operations ,Transplant Center ,Dillon Ren Rong Pang ,Jibing Yang ,Juvenile Diabetes Research Foundation ,National Institutes ,Diabetes ,Ndocrine ,Pancreas ,Type 1 Diabetes ,Flood ,Fell ,Glucose ,Hospital ,Immune System ,Insulin ,Liver ,Medical School ,Medicine ,Research ,Surgery ,Transplant ,